Buddha Cancer Centre Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 7 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.50 Cr
- Revenue Growth 43.72%
- Profit Growth -40.84%
- Ebitda -31.52%
- Net Worth 23.01%
- Total Assets 55.13%
About Buddha Cancer Centre
Buddha Cancer Centre Private Limited (BCCPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 April 2017 (Seven years and ten months 15 days old ). Its registered office is in Patna, Bihar, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹1.50 Cr.
Arvind Kumar and Jagdish Yadav serve as directors at the Company.
Company Details
- Location
Patna, Bihar, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74999BR2017PTC034295
- Company No.
034295
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Apr 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Healthcare
Who are the key members and board of directors at Buddha Cancer Centre?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arvind Kumar  | Director | 13-Apr-2017 | Current |
| Jagdish Yadav | Director | 13-Apr-2017 | Current |
Financial Performance of Buddha Cancer Centre.
Buddha Cancer Centre Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 43.72% increase. The company also saw a substantial fall in profitability, with a 40.84% decrease in profit. The company's net worth Soared by an impressive increase of 23.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Buddha Cancer Centre?
Unlock access to Buddha Cancer Centre's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Online Second Opinion (Oso) Private LimitedArvind Kumar is a mutual person
Charges (Loans)
Open Charges
₹15.00 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Idbi Bank Limited : 1.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 May 2022 | Idbi Bank Limited | ₹1.50 Cr | Open |
How Many Employees Work at Buddha Cancer Centre?
Buddha Cancer Centre has a workforce of 69 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Buddha Cancer Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Buddha Cancer Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.